This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Adding F-18 fluroestradiol (FES)-PET/CT imaging to standard of care tests in women with suspected estrogen receptor (ER)-positive breast cancer could save the U.S. millions in healthcare costs, according to a study published May 14 in PLOS One. In a budget impact study, GE HealthCare scientists estimated the approach could save up to $142 million over a five-year period, primarily by increasing true-positive and true-negative test results and reducing the need for biopsies, noted a team led by R
Breast density, obesity, and hormone replacement therapy use are tied to interval breast cancer in Korean women when compared with screen-detected breast cancer, according to research published May 20 in JAMA Network Open. A team led by Boyoung Park, MD, PhD, from Hanyang University in Seoul, South Korea also found that overall mortality from interval breast cancer is comparable with that of screen-detected breast cancer in these women.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Yes, I’ve started the process of creating a small dedicated job board just for independent radiologist-owned private practices. With all the corporate noise out there, I’m hoping we can connect radiologists looking for the real deal with those groups who are doing it. Still a ways to go, but feel free to reach out to me at ben@benwhite.com if your group is interested, and I’ll get back to you when things are ready.
A new portable ultrasound system is set to potentially reduce wait times for patients with suspected injuries to the upper limbs visiting hospital emergency departments.
Incorporating dynamic contrast-enhanced MRI, a deep learning model demonstrated a 20 percent higher AUC in external validation testing than clinical factors alone and over a 17 percent higher AUC than radiological factors alone in predicting proliferative hepatocellular carcinoma (HCC).
The article looks into overcoming addiction through professional treatment, lifestyle changes, and the power of supportive community networks. The post What It Takes To Overcome Addiction and Get a Fresh Start in Life appeared first on Open MedScience.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
I went for my annual checkup with my PCP this past week where she recommended “all the preventative things.” As the list was wrapped up, she asked, “Any questions?” I quickly responded, “Yes, do the providers you are referring me to use Artificial Intelligence (AI) assisted imaging or tools?” She was noticeably caught off guard by my question and shared that she did not know.
A 67-year-old woman with a history of atrial fibrillation on apixaban presents to the ED for epistaxis that began 30 minutes ago. Her bleeding is difficult to control with direct nasal pressure and topical agents but resolves with silver nitrate cauterization. Her vital signs are within normal limits. How should this patient’s apixaban be managed? Administer a one-time dose of intravenous vitamin K Administer andexanet alfa Bolus 1 unit of prothrombin complex concentrate Give intravenous tranexa
Rudisill K, Mathur N and Kalyanpur A. A teleradiology network for the improvement of healthcare and patient management in the developing countries of the African continent. May-2024 Learn More: [link] AuthorsArjun Kalyanpur, Neetika Mathur, Rudisill K The post A teleradiology network for the improvement of healthcare and patient management in the developing countries of the African continent appeared first on Teleradiology Solutions | Company for Teleradiology Services.
I went for my annual checkup with my PCP this past week where she recommended “all the preventative things.” As the list was wrapped up, she asked, “Any questions?” I quickly responded, “Yes, do the providers you are referring me to use Artificial Intelligence (AI) assisted imaging or tools?” She was noticeably caught off guard by my question and shared that she did not know.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
At Intelerad, we understand that every journey in healthcare is about seeking and providing answers. Today, we are sharing the next chapter of our story: a reimagined and refined brand identity that more accurately encapsulates our commitment to simplifying the search for answers for both clinicians and patients. This reimagined version of Intelerad is born from a deep reflection on our mission and a clear vision for our future.
Now more than ever it is important for an organization to develop current leaders , but also to develop future leaders through the acceleration of leadership development programs. What could be more important to the long-term success of an organization than the choice and development of future leaders? To foster the development of potential successors, companies need to build action plans to grow their leadership bench strength.
milla1cf Mon, 05/20/2024 - 07:00 May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation oncology physician, researcher and thought leader Steven E. Finkelstein, M.D., DABR, FACRO , has joined its care team as Director of the Center of Advanced Radiation Excellence (CARE) and Director of Radiation Oncology Research.
At Intelerad, we understand that every journey in healthcare is about seeking and providing answers. Today, we are sharing the next chapter of our story: a reimagined and refined brand identity that more accurately encapsulates our commitment to simplifying the search for answers for both clinicians and patients. This reimagined version of Intelerad is born from a deep reflection on our mission and a clear vision for our future.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
milla1cf Mon, 05/20/2024 - 08:00 May 20, 2024 — Exo (pronounced “echo”), a medical imaging software and devices company, announced the release of Exo Works Connect , a tailored package of its Exo Works point-of-care ultrasound (POCUS) workflow solution designed for healthcare organizations that want to drive fast implementation and adoption of POCUS.
When it comes to X-rays, the process is more involved than simply scheduling an appointment. A critical element is the requisition form, a document that ensures your imaging test meets your specific needs.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
306 
Let's personalize your content